[Impact of neoadjuvant chemotherapy on the survival of patients with stage IIIc and IV epithelial ovarian cancer].

Yan, Xin; An, Na; Jiang, Guo-Qing; Gao, Min; Gao, Yu-Nong

Yan, Xin; An, Na; Jiang, Guo-Qing; Gao, Min; Gao, Yu-Nong.

Affiliation

Yan X; Department of Gynecological Oncology, Peking University School of Oncology, Beijing Cancer Hospital, Beijing Institute for Cancer Research, Beijing 100036, China.

Zhonghua Zhong Liu Za Zhi ; 30(4): 298-301, 2008 Apr.

Article in Zh | MEDLINE | ID: mdl-18788637

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cystadenocarcinoma, Papillary/drug therapy; Neoadjuvant Therapy; Ovarian Neoplasms/drug therapy; Adult; Aged; Cisplatin/therapeutic use; Cyclophosphamide/therapeutic use; Cystadenocarcinoma, Papillary/pathology; Cystadenocarcinoma, Papillary/surgery; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms/pathology; Ovarian Neoplasms/surgery; Paclitaxel; Retrospective Studies; Survival Rate; Taxoids/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Cystadenocarcinoma, Papillary / Neoadjuvant Therapy Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2008 Document type: Article Affiliation country: China

Search on Google

Add to My VHL

XML

PubMed Links